The CTLA4-Ig used did not deplete cells, as evidenced by the similar numbers of DCs in Rb-treated LCMV-Cl13 infected mice given isotype or CTLA4-Ig, that were both higher than LCMV-Cl13 infection alone (Figure 3C). The gene discussed is RB1; the disease is infection.